Gemma L. Nixon

Generation of quinolone antimalarials targeting the <i>Plasmodium falciparum</i> mitochondrial respiratory chain for the treatment and prophylaxis of malaria

Giancarlo A. Biagini, Nicholas Fisher, Alison E. Shone et al. · Proceedings of the National Academy of Sciences · 2012 · 159 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides

Rachel H. Clare, Catherine Bardelle, Paul Harper et al. · Nature Communications · 2018 · 130 citations · Full text

Pharmacy, Infectious Diseases, Medicinal Chemistry +17

Identification of a 1,2,4,5‐Tetraoxane Antimalarial Drug‐Development Candidate (RKA 182) with Superior Properties to the Semisynthetic Artemisinins

Paul M. O’Neill, Richard K. Amewu, Gemma L. Nixon et al. · Angewandte Chemie International Edition · 2010 · 125 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting <i>Plasmodium falciparum</i> Type II NADH:Quinone Oxidoreductase (PfNDH2)

Chandrakala Pidathala, Richard K. Amewu, Bénédicte Pacorel et al. · Journal of Medicinal Chemistry · 2012 · 110 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

AWZ1066S, a highly specific anti- <i>Wolbachia</i> drug candidate for a short-course treatment of filariasis

W. David Hong, Farid Benayoud, Gemma L. Nixon et al. · Proceedings of the National Academy of Sciences · 2019 · 71 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17